A detailed history of Capital Performance Advisors LLP transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Capital Performance Advisors LLP holds 715 shares of MEDP stock, worth $258,093. This represents 0.08% of its overall portfolio holdings.

Number of Shares
715
Previous 137 421.9%
Holding current value
$258,093
Previous $45,000 426.67%
% of portfolio
0.08%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$308.93 - $363.58 $178,561 - $210,149
578 Added 421.9%
715 $237,000
Q3 2024

Nov 01, 2024

BUY
$320.58 - $457.29 $43,919 - $62,648
137 New
137 $45,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $11.2B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Capital Performance Advisors LLP Portfolio

Follow Capital Performance Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Performance Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Capital Performance Advisors LLP with notifications on news.